97 related articles for article (PubMed ID: 31626714)
1. Voltage-gated sodium channels β3 subunit promotes tumorigenesis in hepatocellular carcinoma by facilitating p53 degradation.
Li S; Han J; Guo G; Sun Y; Zhang T; Zhao M; Xu Y; Cui Y; Liu Y; Zhang J
FEBS Lett; 2020 Feb; 594(3):497-508. PubMed ID: 31626714
[TBL] [Abstract][Full Text] [Related]
2. Nogo-B receptor promotes the chemoresistance of human hepatocellular carcinoma via the ubiquitination of p53 protein.
Dong C; Zhao B; Long F; Liu Y; Liu Z; Li S; Yang X; Sun D; Wang H; Liu Q; Liang R; Li Y; Gao Z; Shao S; Miao QR; Wang L
Oncotarget; 2016 Feb; 7(8):8850-65. PubMed ID: 26840457
[TBL] [Abstract][Full Text] [Related]
3. MYL6B, a myosin light chain, promotes MDM2-mediated p53 degradation and drives HCC development.
Xie X; Wang X; Liao W; Fei R; Wu N; Cong X; Chen Q; Wei L; Wang Y; Chen H
J Exp Clin Cancer Res; 2018 Feb; 37(1):28. PubMed ID: 29439719
[TBL] [Abstract][Full Text] [Related]
4. BIRC6 promotes hepatocellular carcinogenesis: interaction of BIRC6 with p53 facilitating p53 degradation.
Tang W; Xue R; Weng S; Wu J; Fang Y; Wang Y; Ji L; Hu T; Liu T; Huang X; Chen S; Shen X; Zhang S; Dong L
Int J Cancer; 2015 Mar; 136(6):E475-87. PubMed ID: 25196217
[TBL] [Abstract][Full Text] [Related]
5. An oral 2-hydroxypropyl-β-cyclodextrin-loaded spirooxindole-pyrrolizidine derivative restores p53 activity via targeting MDM2 and JNK1/2 in hepatocellular carcinoma.
Gao X; Wei M; Shan W; Liu Q; Gao J; Liu Y; Zhu S; Yao H
Pharmacol Res; 2019 Oct; 148():104400. PubMed ID: 31425749
[TBL] [Abstract][Full Text] [Related]
6. Sirt3 inhibits hepatocellular carcinoma cell growth through reducing Mdm2-mediated p53 degradation.
Zhang YY; Zhou LM
Biochem Biophys Res Commun; 2012 Jun; 423(1):26-31. PubMed ID: 22609775
[TBL] [Abstract][Full Text] [Related]
7. Heat shock protein gp96 decreases p53 stability by regulating Mdm2 E3 ligase activity in liver cancer.
Wu B; Chu X; Feng C; Hou J; Fan H; Liu N; Li C; Kong X; Ye X; Meng S
Cancer Lett; 2015 Apr; 359(2):325-34. PubMed ID: 25637791
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of HURP inhibits the proliferation of hepacellular carcinoma cells via downregulation of gankyrin and accumulation of p53.
Kuo TC; Chang PY; Huang SF; Chou CK; Chao CC
Biochem Pharmacol; 2012 Mar; 83(6):758-68. PubMed ID: 22230478
[TBL] [Abstract][Full Text] [Related]
9. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
10. The E3 Ligase RING1 Targets p53 for Degradation and Promotes Cancer Cell Proliferation and Survival.
Shen J; Li P; Shao X; Yang Y; Liu X; Feng M; Yu Q; Hu R; Wang Z
Cancer Res; 2018 Jan; 78(2):359-371. PubMed ID: 29187402
[TBL] [Abstract][Full Text] [Related]
11. NCPMF-60 induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells.
Dai QS; Liu W; Wang XB; Lu N; Gong DD; Kong LY; Guo QL
Anticancer Drugs; 2011 Jan; 22(1):46-57. PubMed ID: 20948430
[TBL] [Abstract][Full Text] [Related]
12. Δ40p53α suppresses tumor cell proliferation and induces cellular senescence in hepatocellular carcinoma cells.
Ota A; Nakao H; Sawada Y; Karnan S; Wahiduzzaman M; Inoue T; Kobayashi Y; Yamamoto T; Ishii N; Ohashi T; Nakade Y; Sato K; Itoh K; Konishi H; Hosokawa Y; Yoneda M
J Cell Sci; 2017 Feb; 130(3):614-625. PubMed ID: 27980070
[TBL] [Abstract][Full Text] [Related]
13. MDM2-NFAT1 dual inhibitor, MA242: Effective against hepatocellular carcinoma, independent of p53.
Wang W; Cheng JW; Qin JJ; Hu B; Li X; Nijampatnam B; Velu SE; Fan J; Yang XR; Zhang R
Cancer Lett; 2019 Sep; 459():156-167. PubMed ID: 31181320
[TBL] [Abstract][Full Text] [Related]
14. Fusaric Acid Induces DNA Damage and Post-Translational Modifications of p53 in Human Hepatocellular Carcinoma (HepG
Ghazi T; Nagiah S; Tiloke C; Sheik Abdul N; Chuturgoon AA
J Cell Biochem; 2017 Nov; 118(11):3866-3874. PubMed ID: 28387973
[TBL] [Abstract][Full Text] [Related]
15. HMGA2 promotes intestinal tumorigenesis by facilitating MDM2-mediated ubiquitination and degradation of p53.
Wang Y; Hu L; Wang J; Li X; Sahengbieke S; Wu J; Lai M
J Pathol; 2018 Dec; 246(4):508-518. PubMed ID: 30175854
[TBL] [Abstract][Full Text] [Related]
16. [ShRNA-mediated silencing of MDM2 inhibits growth of HepG2 hepatocellular carcinoma cells xenografted in nude mice].
Zhao YY; Li YG; Sun YJ; Liu HP; Yang ZC; Zhang DD; Zhao CY
Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):213-7. PubMed ID: 23967744
[TBL] [Abstract][Full Text] [Related]
17. A GYS2/p53 Negative Feedback Loop Restricts Tumor Growth in HBV-Related Hepatocellular Carcinoma.
Chen SL; Zhang CZ; Liu LL; Lu SX; Pan YH; Wang CH; He YF; Lin CS; Yang X; Xie D; Yun JP
Cancer Res; 2019 Feb; 79(3):534-545. PubMed ID: 30584071
[TBL] [Abstract][Full Text] [Related]
18. UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop.
Zhang XW; Wang XF; Ni SJ; Qin W; Zhao LQ; Hua RX; Lu YW; Li J; Dimri GP; Guo WJ
J Pathol; 2015 Mar; 235(4):656-67. PubMed ID: 25382750
[TBL] [Abstract][Full Text] [Related]
19. Iron-dependent regulation of MDM2 influences p53 activity and hepatic carcinogenesis.
Dongiovanni P; Fracanzani AL; Cairo G; Megazzini CP; Gatti S; Rametta R; Fargion S; Valenti L
Am J Pathol; 2010 Feb; 176(2):1006-17. PubMed ID: 20019189
[TBL] [Abstract][Full Text] [Related]
20. SIX1 and DACH1 influence the proliferation and apoptosis of hepatocellular carcinoma through regulating p53.
Cheng Q; Ning D; Chen J; Li X; Chen XP; Jiang L
Cancer Biol Ther; 2018 May; 19(5):381-390. PubMed ID: 29333942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
